Log in to save to my catalogue

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fi...

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9043040

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Thoracic Society

More information

Scope and Contents

Contents

RationaleInhaled tobramycin and oral azithromycin are common chronic therapies in people with cystic fibrosis and Pseudomonas aeruginosa airway infection. Some studies have shown that azithromycin can reduce the ability of tobramycin to kill P. aeruginosa. This trial was done to test the effects of combining azithromycin with inhaled tobramycin on...

Alternative Titles

Full title

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9043040

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9043040

Other Identifiers

ISSN

0040-6376

E-ISSN

1468-3296

DOI

10.1136/thoraxjnl-2021-217782

How to access this item